U.S., Jan. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07364981) titled 'Gaze Contingent Attentional Reinforcement in Major Depressive Disorder' on Dec. 29, 2025.
Brief Summary: The main objective of this randomized controlled trial is to evaluate whether a gaze-contingent feedback task using negative reinforcement can serve as an effective attention-modification procedure and contribute to the treatment of Major Depressive Disorder (MDD).
Study Start Date: Jan. 01
Study Type: INTERVENTIONAL
Condition:
Major Depressive Disorder (MDD)
Intervention:
BEHAVIORAL: Aversive white noise
Participants will receveve gaze-contingent negative-reinforcement feedback according to their viewing patterns, such th...